The only meaningful comparison context is against the other agents in the class, covered in our Retatrutide vs Semaglutide vs Tirzepatide analysis, and the two entry points for the protocol itself are the 5 mg vial protocol for a gentle start and the 30 mg vial protocol for higher maintenance targets
In the context of clinical practice, it may be important to assess for symptoms of eating disorders/disordered eating behaviors, mood instability, and general psychosocial functioning as well as quality of life, social support, health behaviors, and readiness to change prior to the initiation of and throughout the course of GLP-1 treatment [30]
PlexusDx recommends that patients combining semaglutide with Synthroid request TSH and free T4 testing at baseline, then at 8-12 weeks after starting GLP-1 therapy, and again 6 months into treatment if weight loss is progressing
What to Realistically Expect From NAD+ Alongside GLP-1 Therapy NAD+ is not a GLP-1 amplifier